NCT06976008View on ClinicalTrials.gov

CMV-associated Immunomodulation in Renal Transplant Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2029

Study Completion Date

October 1, 2029

Conditions
Kidney Transplantation
Interventions
OTHER

blood sampling

Blood samples will be taken at different timepoints following CMV viremia to evaluate the impact of CMV viremia over time.

Trial Locations (4)

75015

Hôpital européen Georges Pompidou, Paris

Hôpital Necker-Enfants Malades, Paris

Insitut Pasteur, Paris

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER